AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2013 | $7,882,000 | – | 1,863,400 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 2,295,000 | $38,900,000 | 6.85% |
| Baker Brothers Advisors | 38,513,713 | $652,807,000 | 6.66% |
| Realm Partners LLC | 300,000 | $5,085,000 | 3.92% |
| Miura Global Management | 2,758,000 | $46,748,000 | 3.52% |
| WATER ISLAND CAPITAL LLC | 10,612,846 | $179,887,740,000 | 3.00% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 641,056 | $10,866,000 | 2.72% |
| Verition Fund Management LLC | 703,900 | $11,931,000 | 2.67% |
| GLAZER CAPITAL, LLC | 1,004,815 | $17,032,000 | 2.46% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 716,994 | $12,153,000 | 2.45% |
| Rock Springs Capital Management LP | 1,100,000 | $18,645,000 | 2.18% |